Guidelines for Stability Studies of Generic Drugs as per US FDA Guidance

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability studies for generic drugs in compliance with US FDA requirements. This SOP ensures that stability data supports the quality, safety, and efficacy of generic drugs throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for generic drugs intended for the US market.

3) Responsibilities

Stability Testing Team: Responsible for conducting stability studies and documenting results for generic drugs as per US FDA guidelines.

Quality Assurance (QA) Team: Responsible for reviewing and approving stability study protocols and reports.

Regulatory Affairs Team: Responsible for ensuring that stability studies comply with US FDA requirements.

4) Procedure

4.1 Preparation for Stability Testing

4.1.1 Obtain and review the latest US FDA guidance

for stability testing of generic drugs.

4.1.2 Develop a stability protocol specific to generic drugs, including study design, testing schedule, storage conditions, and testing parameters as per FDA guidelines.

4.2 Selection of Batches and Samples

4.2.1 Select representative batches of the generic drug, typically three primary batches manufactured using the proposed production process.

4.2.2 Prepare sufficient samples to cover the entire study duration, considering the number of time points and tests to be conducted.

4.3 Defining Storage Conditions and Time Points

4.3.1 Define the storage conditions according to FDA guidelines, typically including:

• Long-term stability: 25°C ± 2°C/60% RH ± 5% RH
• Accelerated stability: 40°C ± 2°C/75% RH ± 5% RH

4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.

4.4 Conducting Stability Tests

4.4.1 Store samples under the defined conditions, monitoring temperature and humidity to ensure compliance with the set parameters.

4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including physical, chemical, microbiological, and functional tests, as applicable.

4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.

5) Abbreviations, if any

FDA: United States Food and Drug Administration
QA: Quality Assurance
RH: Relative Humidity

6) Documents, if any

Stability protocol, stability data sheets, stability testing records, stability report, submission package to FDA.

7) Reference, if any

FDA Guidance for Industry: Stability Testing of Generic Drug Products.

8) SOP Version

Version 1.0